B‐type natriuretic peptide is predictive of hospitalization in community‐dwelling elderly without heart diseases

Aim:  To examine prospectively the relationship between plasma B‐type natriuretic peptide (BNP) levels in community‐dwelling elderly and their hospitalization.

[1]  R. Abbott,et al.  Lower Levels of Serum Albumin and Total Cholesterol Associated with Decline in Activities of Daily Living and Excess Mortality in a 12‐Year Cohort Study of Elderly Japanese , 2008, Journal of the American Geriatrics Society.

[2]  T. Auyeung,et al.  Prognostic significance of admission electrolyte disturbances in older people: A retrospective cohort study , 2007 .

[3]  L. Ferrucci,et al.  Magnitude of Underascertainment of Impaired Kidney Function in Older Adults with Normal Serum Creatinine , 2007, Journal of the American Geriatrics Society.

[4]  D. Spodick,et al.  Frequency of interatrial block in patients with sinus rhythm hospitalized for stroke and comparison to those without interatrial block. , 2007, The American journal of cardiology.

[5]  D. Tate,et al.  Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease. , 2006, The American journal of cardiology.

[6]  M. Mcmurdo,et al.  B‐Type Natriuretic Peptide Is Associated with Mortality in Older Functionally Impaired Patients , 2005, Journal of the American Geriatrics Society.

[7]  P. Hildebrandt,et al.  N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. , 2005, JAMA.

[8]  M. Enriquez-Sarano,et al.  B-Type Natriuretic Peptide in Organic Mitral Regurgitation: Determinants and Impact on Outcome , 2005, Circulation.

[9]  J. Lommi,et al.  Diagnosing heart failure in aortic valve stenosis , 2004, Journal of internal medicine.

[10]  K. Bailey,et al.  Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction: A Community-Based Study , 2004, Circulation.

[11]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[12]  Bruce M Psaty,et al.  The presence of frailty in elderly persons with chronic renal insufficiency. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  P. Shekelle,et al.  Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. , 2004, Journal of the American College of Cardiology.

[14]  J. Cohn,et al.  Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy , 2004, Circulation.

[15]  U. Dahlström.  Can natriuretic peptides be used for the diagnosis of diastolic heart failure? , 2004, European journal of heart failure.

[16]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[17]  T. Katagiri,et al.  Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. , 2003, The American journal of medicine.

[18]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction , 2002 .

[19]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings , 2002, Circulation.

[20]  N. Arakawa,et al.  Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population , 2002, Heart.

[21]  Y. Aizawa,et al.  Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. , 2001, Japanese circulation journal.

[22]  M. Kinoshita,et al.  Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. , 2000, Japanese circulation journal.

[23]  K. Kangawa,et al.  Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.

[24]  Yasuyuki Nakamura,et al.  Relationship between Left Ventricular Geometry and Brain Natriuretic Peptide Levels in Elderly Subjects , 2000, Gerontology.

[25]  Y. Doi,et al.  Frailty in elderly Japanese , 1999, The Lancet.

[26]  J. Ix,et al.  The Predictive Value of Combined Hypoalbuminemia and Hypocholesterolemia in High Functioning Community‐Dwelling Older Persons: MacArthur Studies of Successful Aging , 1999, Journal of the American Geriatrics Society.

[27]  E. Marcantonio,et al.  Atrial Natriuretic Peptide Level Contributes to a Model of Future Mortality in the Oldest Old , 1998, Journal of the American Geriatrics Society.

[28]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[29]  K. Nakao,et al.  Brain natriuretic peptide predicts mortality in the elderly. , 1997, Heart.

[30]  F. Marumo,et al.  Plasma human brain natriuretic peptide in chronic renal failure. , 1995, Clinical nephrology.

[31]  N. Markandu,et al.  Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. , 1992, Clinical science.

[32]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[33]  Naoto Minamino,et al.  A new natriuretic peptide in porcine brain , 1988, Nature.

[34]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.